Ramón
Lecumberri Villamediana
Consultor Médico
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublications in collaboration with researchers from Hospital General Universitario Gregorio Marañón (22)
2024
-
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis
Cancers, Vol. 16, Núm. 9
-
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246
-
Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing
Clinical and Translational Oncology
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
-
Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study
eClinicalMedicine, Vol. 73
-
The prognostic value of blood cellular indices in pulmonary embolism
American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711
2023
-
COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
Frontiers in Medicine, Vol. 9
-
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry
Viruses, Vol. 14, Núm. 2
2021
-
Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989
-
Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 2, pp. 408-416
2019
-
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
The Lancet Oncology, Vol. 20, Núm. 10, pp. e566-e581
-
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1
2018
-
Cancer-associated thrombosis: Beyond clinical practice guidelines-A multidisciplinary (SEMI-SEOM-SETH) expert consensus
TH Open, Vol. 2, Núm. 4, pp. e373-e386
-
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism
American Journal of Medicine, Vol. 131, Núm. 4, pp. 430-437
2017
-
FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence
Clinical and Translational Oncology, Vol. 19, Núm. 8, pp. 997-1009
2015
-
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs
American Journal of Medicine, Vol. 128, Núm. 1, pp. 90.e9-90.e15
-
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry
Thrombosis Journal, Vol. 13, Núm. 1